Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.
Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals
Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.